Spots Global Cancer Trial Database for Sphenopalatine Ganglion Block and Pain Management in Neurosurgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sphenopalatine Ganglion Block and Pain Management in Neurosurgery
Official Title: Sphenopalatine Ganglion Block and Pain Management in Neurosurgery
Study ID: NCT05136625
Study Description
Brief Summary: Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not otherwise explained. A moderate to severe pain affects from 60 to 84% of patients. Sphenopalatine ganglion block has been successfully used in patients with chronic or acute headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries. There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull pin closure. This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in reducing pain after a neurosurgical supratentorial craniotomy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sant'Anna Hospital, Ferrara, Emilia Romagna, Italy
Contact Details
Name: Pasquale De Bonis, MD PhD
Affiliation: Università degli Studi di Ferrara
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
